<DOC>
	<DOCNO>NCT00958776</DOCNO>
	<brief_summary>A Phase 3 , multicenter , randomize , double-blind , control study evaluate efficacy safety peramivir administer intravenously addition standard care compare standard care alone adults adolescent hospitalize due serious influenza .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety IV Peramivir Addition Standard Care Compared Standard Care Alone Adults Adolescents Who Are Hospitalized Due Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Peramivir</mesh_term>
	<criteria>Age ≥12 year age , male female . Able provide inform consent , consent may provide guardian , unless informed consent provide guardian legally authorize representative consistent applicable local ethical concern , procedure , directive and/or guideline . Subject must least one follow clinical presentation Screening : 1 . Oral temperature ≥ 38.0 °C ( ≥100.4 °F ) , ≥38.6°C ( ≥101.4 °F ) tympanic rectal OR 2 . Oxygen saturation &lt; 92 % , OR 3 . Two follow three vital sign : Respiration rate &gt; 24/minute , Heart rate &gt; 100/minute , Systolic BP &lt; 90 mmHg Presence least one respiratory symptom ( cough , sore throat , nasal congestion ) severity ( mild , moderate , severe ) . Presence least one constitutional symptom ( headache , myalgia , feverishness , fatigue ) severity ( mild , moderate , severe ) . Onset illness 72 hour presentation . Note : Time onset illness define earlier either ( 1 ) time temperature first measure elevate , OR ( 2 ) time subject experienced presence least one respiratory symptom AND presence least one constitutional symptom . Either : Severity illness , Investigator 's judgment , justifies hospitalization subject supportive care . OR Presence one follow factor : Age ≥60 year . Presence chronic obstructive pulmonary disease ( COPD ) chronic lung disease require daily pharmacotherapy . Current history congestive heart failure angina . Presence diabetes mellitus , clinically stable unstable . Transcutaneous oxygen saturation &lt; 94 % without supplemental oxygen least 5 minute , medically significant decrease oxygen saturation establish baseline value ( investigative site altitude &gt; 2000 ft sea level utilize different criterion oxygen saturation ) . History chronic renal impairment require peritoneal dialysis . Serum creatinine &gt; 2.0 mg/dL &gt; 177 μmol/L . Diagnosis Influenza satisfy one following : 1 . Clinical Influenza Positive Diagnostic Test . Subjects positive rapid antigen test ( RAT ) influenza A and/or influenza B ( use Sponsorapproved test kit ) , positive test ( use methodology ) influenza A and/or B virus antigen RNA perform clinical laboratory screening/enrollment evaluation eligible enrollment . OR 2 . Clinical Influenza Negative Rapid Antigen Test ( RAT ) . Subjects negative RAT test may enrol site approve Sponsor enroll subject , base documentation outbreak influenza community . An influenza outbreak may document catchment area hospital via one follow method : 1 ) local confirmation influenza A B infection current influenza season ) institution 's local laboratory , b ) local public health system , c ) national public health system , ) laboratory recognize multinational influenza surveillance scheme European Influenza Surveillance Network ( EISN ) ; 2 ) prior enrollment RAT positive subject study institution current influenza season . Subjects hospitalize great 24 hour ( include time spent Emergency Department ) . Treatment dose ( ) rimantadine , amantadine , ribavirin , zanamivir , oseltamivir previous 7 day . Blood platelet count &lt; 20 x 109/L time screen evaluation . Serum bilirubin &gt; 6 mg/dL &gt; 105 μmol/L time screen evaluation . Serum ALT AST &gt; 5 time upper limit normal time screen evaluation . Congestive heart failure NYHA Class III Class IV functional status . Serum creatinine &gt; 5.0 mg/dL &gt; 500 μmol/L time screen evaluation . Subjects require peritoneal dialysis . Altered neurologic status define Glasgow Coma Score ≤ 9 , unless medically induce . Females pregnant ( positive urine serum pregnancy test screen evaluation ) breastfeeding . Actively undergoing systemic chemotherapy radiotherapy treatment malignancy . Subjects complete treatment 30 day prior enrollment exclude . Hormone treatment cancer also exclude . Prior hematopoietic stem cell transplantation solid organ transplant previous 4 month . HIV infection know CD4 count &lt; 200 cells/mm3 unless stable highly active antiretroviral therapy ( HAART ) least 6 month . Presence preexist chronic infection undergo require medical therapy ( eg , tuberculosis ) . Subjects chronic osteomyelitis Hepatitis B C require treatment exclude . Presence preexist illness , opinion investigator , would place subject unreasonably increase risk participation study . Previous treatment intravenous intramuscular peramivir . Participation subject study experimental treatment condition within 30 day prior time screen evaluation . Subjects diagnose Cystic Fibrosis . Subjects confirm clinical evidence acute noninfluenzal infection time screen evaluation . Subjects , judgment investigator , unlikely comply requirement protocol .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Hospitalized</keyword>
	<keyword>Antiviral</keyword>
	<keyword>Flu</keyword>
</DOC>